Author Correction: Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway

類似資料

• Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway
  著者:: Wenbo Kang, 等
  出版事項: (2024-08-01)
• Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway
  著者:: Wenjun Li, 等
  出版事項: (2020-02-01)
• Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway
  著者:: Hui Shan, 等
  出版事項: (2022-11-01)
• Hyperoside attenuates osteoarthritis progression by targeting PI3K/Akt/NF-κB signaling pathway: In vitro and in vivo studies
  著者:: Yang Yang, 等
  出版事項: (2022-08-01)
• Eriodictyol attenuates TNBS‐induced ulcerative colitis through repressing TLR4/NF‐kB signaling pathway in rats
  著者:: Li‐Hong Hu, 等
  出版事項: (2021-09-01)